vs
Side-by-side financial comparison of Burke & Herbert Financial Services Corp. (BHRB) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
Burke & Herbert Financial Services Corp. is the larger business by last-quarter revenue ($86.5M vs $75.5M, roughly 1.1× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 4.9%). Burke & Herbert Financial Services Corp. produced more free cash flow last quarter ($96.2M vs $14.4M). Over the past eight quarters, Burke & Herbert Financial Services Corp.'s revenue compounded faster (81.1% CAGR vs 31.3%).
Burke & Herbert Financial Services Corp is a U.S.-based regional financial holding company, offering personal and commercial banking, wealth management, residential mortgage lending, and small business financing services. Its core market covers Virginia and adjacent Mid-Atlantic regions, serving retail consumers, SMEs, and high-net-worth clients.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
BHRB vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $86.5M | $75.5M |
| Net Profit | $30.2M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | 43.8% | 22.7% |
| Net Margin | 34.9% | — |
| Revenue YoY | 4.9% | 27.7% |
| Net Profit YoY | 52.8% | — |
| EPS (diluted) | $1.98 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $86.5M | $75.5M | ||
| Q3 25 | $85.4M | $54.5M | ||
| Q2 25 | $87.1M | $52.4M | ||
| Q1 25 | $83.0M | $46.0M | ||
| Q4 24 | $82.5M | $59.1M | ||
| Q3 24 | $83.8M | $80.5M | ||
| Q2 24 | $69.3M | $47.1M | ||
| Q1 24 | $26.4M | $43.8M |
| Q4 25 | $30.2M | — | ||
| Q3 25 | $30.0M | $8.8M | ||
| Q2 25 | $29.9M | $5.9M | ||
| Q1 25 | $27.2M | $3.0M | ||
| Q4 24 | $19.8M | — | ||
| Q3 24 | $27.6M | $20.3M | ||
| Q2 24 | $-16.9M | $-4.5M | ||
| Q1 24 | $5.2M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
| Q4 25 | 43.8% | 22.7% | ||
| Q3 25 | 43.3% | 17.6% | ||
| Q2 25 | 42.7% | 12.7% | ||
| Q1 25 | 39.6% | 8.7% | ||
| Q4 24 | 24.6% | 22.6% | ||
| Q3 24 | 39.2% | 27.4% | ||
| Q2 24 | -27.5% | -4.6% | ||
| Q1 24 | 22.3% | -5.3% |
| Q4 25 | 34.9% | — | ||
| Q3 25 | 35.1% | 16.2% | ||
| Q2 25 | 34.3% | 11.2% | ||
| Q1 25 | 32.8% | 6.5% | ||
| Q4 24 | 24.0% | — | ||
| Q3 24 | 33.0% | 25.2% | ||
| Q2 24 | -24.4% | -9.6% | ||
| Q1 24 | 19.8% | -11.0% |
| Q4 25 | $1.98 | $0.26 | ||
| Q3 25 | $1.97 | $0.17 | ||
| Q2 25 | $1.97 | $0.12 | ||
| Q1 25 | $1.80 | $0.06 | ||
| Q4 24 | $1.72 | $0.40 | ||
| Q3 24 | $1.82 | $0.41 | ||
| Q2 24 | $-1.41 | $-0.09 | ||
| Q1 24 | $0.69 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $854.6M | $130.3M |
| Total Assets | $7.9B | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | $854.6M | $130.3M | ||
| Q3 25 | $822.2M | $115.3M | ||
| Q2 25 | $780.0M | $104.7M | ||
| Q1 25 | $758.0M | $97.1M | ||
| Q4 24 | $730.2M | $92.1M | ||
| Q3 24 | $738.1M | $71.1M | ||
| Q2 24 | $693.1M | $48.5M | ||
| Q1 24 | $319.3M | $51.0M |
| Q4 25 | $7.9B | $216.3M | ||
| Q3 25 | $7.9B | $202.9M | ||
| Q2 25 | $8.1B | $194.9M | ||
| Q1 25 | $7.8B | $196.2M | ||
| Q4 24 | $7.8B | $213.3M | ||
| Q3 24 | $7.9B | $220.7M | ||
| Q2 24 | $7.8B | $205.0M | ||
| Q1 24 | $3.7B | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $107.9M | $14.4M |
| Free Cash FlowOCF − Capex | $96.2M | $14.4M |
| FCF MarginFCF / Revenue | 111.2% | 19.1% |
| Capex IntensityCapex / Revenue | 13.5% | 0.0% |
| Cash ConversionOCF / Net Profit | 3.57× | — |
| TTM Free Cash FlowTrailing 4 quarters | $164.1M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $107.9M | $14.4M | ||
| Q3 25 | $39.3M | $9.7M | ||
| Q2 25 | $41.0K | $14.1M | ||
| Q1 25 | $37.6M | $3.6M | ||
| Q4 24 | $85.8M | $15.6M | ||
| Q3 24 | $47.8M | $11.0M | ||
| Q2 24 | $-46.0M | $1.0M | ||
| Q1 24 | $7.1M | $11.2M |
| Q4 25 | $96.2M | $14.4M | ||
| Q3 25 | $35.4M | $9.7M | ||
| Q2 25 | $-3.4M | $14.1M | ||
| Q1 25 | $35.9M | $3.6M | ||
| Q4 24 | $81.2M | $15.6M | ||
| Q3 24 | $46.0M | $11.0M | ||
| Q2 24 | $-47.0M | $1.0M | ||
| Q1 24 | $5.6M | — |
| Q4 25 | 111.2% | 19.1% | ||
| Q3 25 | 41.5% | 17.7% | ||
| Q2 25 | -3.9% | 26.8% | ||
| Q1 25 | 43.2% | 7.7% | ||
| Q4 24 | 98.5% | 26.4% | ||
| Q3 24 | 55.0% | 13.7% | ||
| Q2 24 | -67.8% | 2.1% | ||
| Q1 24 | 21.2% | — |
| Q4 25 | 13.5% | 0.0% | ||
| Q3 25 | 4.5% | 0.0% | ||
| Q2 25 | 3.9% | 0.0% | ||
| Q1 25 | 2.1% | 0.1% | ||
| Q4 24 | 5.5% | 0.0% | ||
| Q3 24 | 2.1% | 0.0% | ||
| Q2 24 | 1.5% | 0.0% | ||
| Q1 24 | 5.7% | 0.0% |
| Q4 25 | 3.57× | — | ||
| Q3 25 | 1.31× | 1.10× | ||
| Q2 25 | 0.00× | 2.41× | ||
| Q1 25 | 1.38× | 1.21× | ||
| Q4 24 | 4.33× | — | ||
| Q3 24 | 1.73× | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | 1.36× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
